GP-119

N/A

Report date: 2023/01/07 12:17:33
NME

Base Information

Drug NameGP-119
Drug Alias NameGP-119
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGrowth hormone releasing factor agonistsVasoactive intestinal peptide receptor agonists
TargetsGrowth hormone releasing factorVasoactive intestinal peptide receptor
Therapy Area/IndicationsLipodystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGriffon pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesGriffon pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsLipodystrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A